AY05 Commercial Development of Sphingolipids

Have a look at our PowerPoint Introduction and Brochure describing deliverables, differentiators and case studies. Eight case studies can also be reviewed.

Objective

The objective of this thorough study was to assist our client in planning the commercial development of sphingolipids as ingredients for various end markets, by providing it with an understanding of the market dynamics and nuances in order to plan how it can do this.
The report provides a number of scenarios along with recommendations as to which are the most favoured, as well as the best, most cost-effective and profitable approaches to the market.

Method

The main contents of the study were based on a large number of sources including in-house databases, government regulators, trade journals, patent databases, scientific journals and existing reports on market sectors in which sphingolipids could be utilised.

CPL carried out an extensive search and review of scientific publications, patents, trade news, regulatory databases and clinical trials databases.

During the course of the study, selected contacts were made with potential users of sphingolipids within the relevant market sectors.

Click to see the contents of the study or look below for an outline.

Table of Contents

Objectives
Background and Scope
Method
Outline Business Plans

    Four Business Plan Scenarios

      Customers
      Segments
      Distribution Channels
      Partners
      Activities
      Resources
      Costs
      Potential Revenues

Principal Findings

    Markets

      Global Nutrition Market
      Infant Nutrition
      Supplements
      Medical Foods

    Products and Players
    Cost-Elasticity of a Sphingolipid Product as a New Ingredient

      Supplements
      Food
      Potential market sizes

    Value Chain
    Distribution Chain
    Clinical Trials and Regulatory
    Overview of Scientific Literature
    News

Conclusions

    Markets

      Infant Nutrition
      Supplements
      Medical Foods

    Players and Products
    Cost-Elasticity

      Product pricing
      Market size

    Value Chain
    Distribution Chain
    Clinical Trials and Regulatory
    Scientific Literature
    Contacts
    News

Recommendations
Markets

    Global Nutrition Market

      Summary of the Value and Growth of Various Market Sectors

    Current Markets for Sphingolipids
    Nutricosmetics

      Markets by region
      Market drivers
      Market constraints

    Infant Nutrition
    Possible Future Markets for Sphingolipids
    Supplements

      The US Supplements Market
      The UK Supplements Market
      Market Drivers

    Medical Food

      Medical Food Ingredients Market

Players and Products

    Summary

      Manufacturers
      Distributors
      Finished Products

    Manufacturers

      22 Companies

    Distributors

      8 Companies

    Examples of Finished Products

      14 Products

Cost-Elasticity of Sphingolipid Product as a New Ingredient

Distribution Chain

    Summary
    Food Distribution Chain in the US
    Functional Foods Distribution Chain
    Supplement Distribution Channels

      Distribution Channels in the US
      Distribution Channels in the UK
      Distribution Channels in Japan
      Distribution Channels in China

    Infant Nutrition Distribution

      Infant Nutrition in China

    Medical Foods Distribution Channels

Clinical Trials and Regulation

    Summary
    Clinical Trials
    Regulations

Scientific Literature

    Selected Scientific Literature Summary

Sphingolipid Patents

    Summary
    Patent Activity of Key Players
    Manufacturing
    Sphingolipid Applications

Contact Reports

    Overview Contact Reports

News Overview

    News Articles

114 Tables
76 Figures

CPL Gallery

Previous Image
Next Image